Retatrutide versus semaglutide comparisons show that this triple agonist may provide even better results than tirzepatide for some people, though it remains in clinical development
It also underscores why the result should not be read as a general fat-burning effect: the trials measured a specific fat compartment in a specific population, using CT imaging, not overall body weight or cosmetic slimming
I have tried countless diets and exercise regimens, but nothing seemed to work long-term
If the dilution is not correct, the run will fail suitability and well need to adjust the dilution to ensure accurate results
SURMOUNT-2, which included participants with type 2 diabetes, showed weight reductions of 12.8% to 15.7% with tirzepatide versus 3.2% with placebo
N Engl J Med 2008;359(18): 18971908